Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 99.1% | 36.6% | 81.4% | 106.7% | 52.7% | 28.1% | 90.1% | 85.0% | 255.6% | 116.6% | 129.2% | 62.0% | 36.3% | 432.8% | 100.8% | 209.0% | (147.8%) | 217.2% | 188.3% | 157.4% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is (190.4%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual FCF to Net Income for Bristol-Myers Squibb Company have been 21.2% over the past three years, and (2,124.8%) over the past five years.
As of today, Bristol-Myers Squibb Company's FCF to Net Income is (190.4%), which is lower than industry median of 109.5%. It indicates that Bristol-Myers Squibb Company's FCF to Net Income is Bad.